Preliminary Investigation of Seeding Mesenchymal Stem Cells on Biodegradable Scaffolds for Vascular Tissue Engineering In Vitro

ASAIO Journal ◽  
2009 ◽  
Vol 55 (6) ◽  
pp. 614-619 ◽  
Author(s):  
Chun-Min Li ◽  
Zhong-Gao Wang ◽  
Yong-Quan Gu ◽  
Jian-De Dong ◽  
Rong-Xin Qiu ◽  
...  
2004 ◽  
Vol 83 (7) ◽  
pp. 523-528 ◽  
Author(s):  
M.T. Duailibi ◽  
S.E. Duailibi ◽  
C.S. Young ◽  
J.D. Bartlett ◽  
J.P. Vacanti ◽  
...  

The recent bioengineering of complex tooth structures from pig tooth bud tissues suggests the potential for the regeneration of mammalian dental tissues. We have improved tooth bioengineering methods by comparing the utility of cultured rat tooth bud cells obtained from three- to seven-day post-natal (dpn) rats for tooth-tissue-engineering applications. Cell-seeded biodegradable scaffolds were grown in the omenta of adult rat hosts for 12 wks, then harvested. Analyses of 12-week implant tissues demonstrated that dissociated 4-dpn rat tooth bud cells seeded for 1 hr onto PGA or PLGA scaffolds generated bioengineered tooth tissues most reliably. We conclude that tooth-tissue-engineering methods can be used to generate both pig and rat tooth tissues. Furthermore, our ability to bioengineer tooth structures from cultured tooth bud cells suggests that dental epithelial and mesenchymal stem cells can be maintained in vitro for at least 6 days.


2019 ◽  
Vol 7 (16) ◽  
pp. 2703-2713 ◽  
Author(s):  
Na Li ◽  
Alex P. Rickel ◽  
Hanna J. Sanyour ◽  
Zhongkui Hong

Stem cell differentiation on a decellularized native blood vessel scaffold under mechanical stimulation for vascular tissue engineering.


2010 ◽  
Vol 38 (3) ◽  
pp. 649-657 ◽  
Author(s):  
Eoin D. O’Cearbhaill ◽  
Mary Murphy ◽  
Frank Barry ◽  
Peter E. McHugh ◽  
Valerie Barron

Nanomedicine ◽  
2019 ◽  
Vol 14 (2) ◽  
pp. 201-214 ◽  
Author(s):  
Hariharan Ezhilarasu ◽  
Asif Sadiq ◽  
Greeshma Ratheesh ◽  
Sreepathy Sridhar ◽  
Seeram Ramakrishna ◽  
...  

Blood ◽  
2008 ◽  
Vol 111 (9) ◽  
pp. 4551-4558 ◽  
Author(s):  
Patrick Au ◽  
Joshua Tam ◽  
Dai Fukumura ◽  
Rakesh K. Jain

Abstract Vascular tissue engineering requires a ready source of endothelial cells and perivascular cells. Here, we evaluated human bone marrow–derived mesenchymal stem cells (hMSCs) for use as vascular progenitor cells in tissue engineering and regenerative medicine. hMSCs expressed a panel of smooth muscle markers in vitro including the cardiac/smooth muscle–specific transcription coactivator, myocardin. Cell-cell contact between endothelial cells and hMSCs up-regulated the transcription of myocardin. hMSCs efficiently stabilized nascent blood vessels in vivo by functioning as perivascular precursor cells. The engineered blood vessels derived from human umbilical cord vein endothelial cells and hMSCs remained stable and functional for more than 130 days in vivo. On the other hand, we could not detect differentiation of hMSCs to endothelial cells in vitro, and hMSCs by themselves could not form conduit for blood flow in vivo. Similar to normal perivascular cells, hMSC-derived perivascular cells contracted in response to endothelin-1 in vivo. In conclusion, hMSCs are perivascular cell precursors and may serve as an attractive source of cells for use in vascular tissue engineering and for the study of perivascular cell differentiation.


Sign in / Sign up

Export Citation Format

Share Document